loader
Please Wait
Applying Filters...

Renejix CDMO Partner for Small Molecule Oral Dosage Forms Renejix CDMO Partner for Small Molecule Oral Dosage Forms

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r0_cep_2019_316___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    PolyPeptide Group

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 PolyPeptide Laboratories (Sweden) AB Limhamn SE (1)

    filter

    01 Terlipressin (1)

    filter

    01 U.S.A (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    PolyPeptide Laboratories (Sweden) A...

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Terlipressin

    PDF Supplier PDF
    URL Supplier Web Content
    R0-CEP 2019-316 - Rev 00
    Valid
    Chemical
    2021-05-21
    2646
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for R0-CEP 2019-316 - Rev 00 of Polypeptide Laboratories (sweden) Ab Limhamn Se

    Looking for Certificates of Suitability (CEPs) for R0-CEP 2019-316 - Rev 00 of Polypeptide Laboratories (sweden) Ab Limhamn Se 1

    20

    Polypeptide Laboratories (sweden) Ab Limhamn Se, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    One of their significant offerings is Terlipressin, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2019-316 - Rev 00

    This Chemical Type CEP, issued on May 21, 2021, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

    Substance Number 2646 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY